Daily News Analysis

Research linked Incentive scheme

stylish_lining

Research linked Incentive scheme

Why in the News?

The Ministry of Science and Technology has written to the Finance Ministry to introduce a Research Linked Incentive (RLI) scheme for the Pharma sector in the upcoming budget of 2024-25.

What is Research linked Incentive scheme?

  1. The RLI scheme has been envisaged on the lines of production-linked incentive (PLI) scheme, to give stimulus to research and development in the field of Science and Technology (S&T).
  2.  The incentives provided to the companies shall total an outlay of Rs. 100 Crore per year, with incremental annual spending in the forthcoming years.
  3. RLI also incorporates policy interventions to harness India’s inherent potential.
  4. The scheme shall operate in addition to the existing incentive R&D schemes available for the Pharma and biotech companies operating in India.

Possible benefits of the scheme:

  1. The incentives provided by the scheme shall enable firm push to Research and development to boost Innovation, that can help to improve India’s ranking in the Global innovation Index (GII) further.

 

 

 

 

  1. Promotes innovation in emerging fields of S&T:
    1. Electric vehicles (EV)
    2. Hydrogen and renewable energy
    3. Sustainable technologies
    4. Artificial intelligence (AI) based smart technologies involving Machine Learning
    5. Semiconductor designing and manufacturing.
  2. Research-linked incentives given sector-specific enables development of sustainable and green technologies in the future.
  3. The scheme shall enable India to shift away from a low-value, high-volume player to a high-value, high-volume player in the global pharma market.

About:

Research & Development in the Pharma sector:

  1. The Pharma R&D processes involves:
    1. Pre-clinical research
    2. Discovery of innovative drugs
    3. Clinical trials of prescription drugs
    4. Preparation and submission of applications for Food and Drug Administration or FDA approval
    5. Designing production processes for the new product
    6. Clinical testing of a new drug against an existing drug to showcase the benefits of the new drug.
    7. Additional clinical trials after a new drug reaches the market
      1. for safety monitoring
      2. Detection of additional side effects that may not have been observed in earlier trials during development
    8. Improvements over existing prescription drugs by developing new dosages and delivery systems and testing for additional potential uses
  2. India’s R&D in Pharma sector:
    1. The gestation period for translation of concept to market may take about 10-15 years, with a >90% attrition rate in the Indian pharma industry.
    2. The need for a early innovation and a cushion for handling the risk of capital needs given the high failure rate stresses the importance of incentives in R&D sector in India.
    3. The average pharma industry funding continues to be around 10%, compared to 15-20% for most large innovators globally. 
    4. Though government grants are provided especially from BIRAC (e.g., the Biotechnology Ignition Grant) and MeiTY, which accounts for about Rs 5-50 lakhs over 6-18 months, it remains largely insufficient for the entire development cycle of drugs.
    5. The R&D Expenditure of India stands at 0.8% of the GDP, way lower than the developed and emerging economies of the world.

 

 
 


UNESCO: R&D intensity as a percentage of GDP (2018)

 

 

 

Union Cabinet Approves National Sports Policy (NSP) 2025

The Union Cabinet, chaired by Prime Minister Narendra Modi, has approved the National Sports Policy (NSP) 2025, aiming to address long-standing challenges and transform India into a global sportin
Share It

CIMMYT’s Financial Crisis

The International Maize and Wheat Improvement Center (CIMMYT), a pivotal institution in the development of agricultural research for maize, wheat, and related crops, is facing significant financia
Share It

Shanghai Cooperation Organisation (SCO)

India's refusal to sign the joint declaration at the Shanghai Cooperation Organisation (SCO) Defence Ministers' meeting in Qingdao, China has been a significant diplomatic development.
Share It

China-Pakistan-Bangladesh Trilateral Meeting

China, Pakistan, and Bangladesh held their first-ever trilateral meeting during the 6th China-South Asia Cooperation Forum.China took the lead in facilitating the dialogue, aiming to boost regiona
Share It

US Imposing Tariffs on India

The US's decision to raise tariffs on India, particularly targeting the continued purchase of Russian oil, has had significant implications for the bilateral trade relationship between the two
Share It

Offshore Wind Energy

As India expands its wind energy capacity, reaching an estimated 51.3 GW by mid-2025, concerns are growing over the environmental impact, particularly on bird populations and marine biodiversity.
Share It

AI-Powered Public Service Delivery in India

India is increasingly embracing Artificial Intelligence (AI) to transform public service delivery, ensuring that services are not only more efficient but also more inclusive and accessible. From e
Share It

Transforming Northeast India

The Act East Policy has played a pivotal role in transforming Northeast India into a key gateway for Southeast Asia, improving the region's infrastructure, economic ties, and regional integration.
Share It

Child Adoption in India

India’s child adoption system faces a number of challenges, but there are ongoing efforts to improve the process. Adoption Statistics Total Adoptions (2024–25): 4,515 children
Share It

permanent settlement for displaced tribals

The discussions surrounding permanent settlement for displaced tribals in India bring into sharp focus the urgent need for a comprehensive and structured approach to address the multi-dimensional issu
Share It

Newsletter Subscription


ACQ IAS
ACQ IAS